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The present study aimed to determine the hepatoprotective activity of a methanol extract
ofMelastomamalabathricum leaves (MEMM)using twoestablished ratmodels. Tengroupsof
rats (nZ 6) were given a once-daily administration of 10% dimethyl sulfoxide (negative
control), 200 mg/kg silymarin (positive control), or MEMM (50, 250, or 500 mg/kg) for 7 days
followed by induction of hepatotoxicity either using paracetamol or carbon tetrachloride.
Blood samples and livers were collected for biochemical and microscopic analysis. Based
on the results obtained, MEMM exhibited a significant (p< 0.05) hepatoprotective activity
against both inducers, as indicated by an improvement in the liver function test. These
observations were supported by the histologic findings. In conclusion, M. malabathricum
leaves possessed hepatoprotective activity, which could be linked to their phytochemical
constituents and antioxidant activity; this therefore requires further in-depth studies.of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400
acopuncture Institute
2.08.002
Hepatoprotection from Melastoma malabathricum 531. Introduction M. malabathricum leaves (MEMM) using various animalThe liver is the key organ of metabolism and, is continu-
ously and variedly exposed to xenobiotics, environmental
pollutants, and chemotherapeutic agents [1]. If the natural
protective mechanisms of the liver are overpowered during
all such exposures, this will lead to hepatic injury. Liver
diseases are a problem worldwide, and the conventional
drugs used in the treatment of liver diseases are sometimes
inadequate and can have serious adverse effects [2]. Thus,
interest and effort have shifted toward medicinal plants as
new sources of hepatoprotective agents [2].
A number of plant-based traditional medicines or
formulations containing herbal extracts are sold in the
market for liver disorders, especially in countries like India
[3], China [4], and Malaysia [4], where the management of
liver disorders by herbal-based drugs or formulations is still
considered to be an intriguing problem [5]. Melastoma
malabathricum L. Smith (family Melastomaceae), a small
shrub native to tropical and temperate Asia, is locally
known to the Malay as Senduduk [6]. The leaves of M.
malabathricum in particular have been traditionally used to
treat various ailments [6] and have been scientifically
demonstrated to possess various pharmacologic activities,
including anti-inflammatory and antioxidant activities [6].
The link between anti-inflammatory, antioxidant, and
hepatoprotective mechanisms has been established else-
where [3,5]. However, to our best knowledge, no attempt
has been made to study the hepatoprotective potential of
M. malabathricum leaves. Thus, it was our aim to deter-
mine the hepatoprotective activity of a methanol extract ofFigure 1 Liver photomicrographs. (A) Normal liver architecture s
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2. Materials and methods
2.1. Plant material and preparation of the extract
The leaves of M. malabathricum were collected from their
natural habitat around Serdang, Selangor, Malaysia,
between August and September 2010, and a new voucher
specimen, ACP-0017, was deposited at the Herbarium of
the Institute of Bioscience, Universiti Putra Malaysia. MEMM
was prepared according to a previously described method
[7]. The ground dried leaves (40 g) were soaked three times
at room temperature for 24 hours with methanol in a 1:20
(w/v) ratio, and the methanol supernatant was evaporated
(at 40C) under reduced pressure to dryness, resulting in
a yield of 12.8 g dried and sticky methanol extract (the
percentage yielded being approximately 32%).
2.2. Animals used
Adult male Sprague-Dawley rats weighing 180e200 g were
used, ethical approval having been obtained from the
Animal Ethics Committee, Universiti Putra Malaysia (refer-
ence number UPM/FPSK/PADS/BR-UUH/00382). The
animals were cared for and handled according to the
methods described by Zakaria et al [8]. Animals were fasted
for 48 hours prior to all assays, and the standard drug
(200 mg/kg silymarin) and the extract were administeredhowing the portal vein (PV), hepatic artery (HA), and bile duct
butting onto the portal tract as a limiting plate of continuous
nt with paracetamol (PCM) showing severe necrosis (N) of the
morrhage (H). (C) Hepatotoxic liver after treatment with CCl4
-induced hepatotoxic liver after pretreatment with 200 mg/kg
d infiltration by lymphocytes (IL). (E) PCM-induced hepatotoxic
oma malabathricum leaves (MEMM), showing focal multilobular
es (IL). (F) CCl4-induced hepatotoxic liver after pretreatment
tocytes, mild steatosis (S), and mild infiltration by lymphocytes
500 mg/kg MEMM showing infiltration of leukocytes (IL), mild
Table 1 Effects of methanol extract of Melastoma malabathricum leaves (MEMM) on aspartate transaminase (AST) and
alanine transaminase (ALT) levels in paracetamol (PCM)- and CCl4-induced hepatotoxicity in rats.
Design of treatment PCM-induced CCl4-induced
AST (U/L) ALT (U/L) AST (U/L) ALT (U/L)
Normal (non-induced) 107.5 8.269 58.40 16.05 107.5 8.269 58.40 16.05
Dimethyl sulfoxide 1396 199.0* 589.8 87.85* 1738 362.8* 804.4 204.2*
200 mg/kg silymarin 612.1 155.4y 309.1 75.76y 720.3 92.04y 467.7 80.61y
50 mg/kg MEMM 952.4 64.04 396.3 66.90 1131 81.85y 749.2 87.49
250 mg/kg MEMM 730 152.5y 373.2 69.47y 790.5 62.53y 357.9 51.29y
500 mg/kg AEMM 457 54.85y 530.7 60.52y 892.3 80.55y 176.3 18.53y
Values are expressed as mean standard error.
*Data differed significantly at p< 0.05 when compared with the normal control group in the relevant column.
yData differed significantly at p< 0.05 when compared with the DMSO-treated (negative control) group in the relevant column.
54 F.H. Kamisan et al.orally (by gavage) with 10% dimethyl sulfoxide (DMSO;
10 ml/kg) as the vehicle.
2.3. Pharmacologic studies
2.3.1. Acute toxicity study in rats
The acute toxicity study involving MEMM was performed
using a single-dose administration of 5000 mg/kg (orally) as
described by Mohamed et al [9]. The effects of a single oral
dose of MEMM were monitored over a 14-day period, and no
symptoms or signs of toxicity were observed in any of the
animals treated.
2.3.2. Hepatoprotective assays
In the hepatoprotective study, doses of 50, 250, and
500 mg/kg MEMM were assayed against paracetamol- (PCM;
3 g/kg) and carbon tetrachloride (CCl4; 0.15 ml/kg)-induced
liver toxicity models [8]. The 10% DMSO was used as the
vehicle group, while silymarin (200 mg/kg) was used as the
standard drug. The test solutions were administered for 7
consecutive days. This was followed, 24 hours after the last
administration of test solutions, by a single oral adminis-
tration of 100% glycerol (the vehicle for diluting the
inducers), PCM, or CCl4. After administering the respective
inducer, the rats were fasted for 48 hours and later
anaesthetized. The blood samples were collected for
analysis of the biochemical parameters. The rats were then
sacrificed, their livers being immediately excised and fixed
in 10% formalin for histopathologic studies.
2.4. Statistical analysis
The results are presented as mean standard error of
mean and analyzed using the one-way analysis of variance
test with the Dunnet post-hoc test, with p< 0.05 as the
limit of significance.
3. Results
The extract exhibited significant (p< 0.05) hep-
atoprotective activity against the CCl4- and PCM-induced
liver models of toxicity by improving liver function, as indi-
cated by the reduction in levels of the liver enzymes aspar-
tate transaminase and alanine transaminase compared withthe control group (Table 1). Histopathologic studies of the
livers removed from the PCM- and CCl4-induced rats pre-
treated with 10% DMSO revealed significant (p< 0.05)
damage to the architecture of the liver, with severe necrosis
of hepatocytes in the parenchymal region and hemorrhage
detected (Fig. 1). These observations were attenuated in the
groups pretreated with MEMM or silymarin. The group
induced with vehicle (10% glycerol) did not show any change
in the level of liver enzymes and, histologically, did not exert
any structural changes (data not shown).4. Discussion
The present study revealed the hepatoprotective potential
of MEMM in CCl4- and PCM-induced liver toxicity models.
CCl4-induced hepatotoxicity involves the action of free
radicals on hepatocytes, leading to cell necrosis. PCM-
induced hepatotoxicity involves the oxidative effect of N-
acetyl-p-benzoquinone-imine, the toxic metabolite of PCM.
This binds to proteins and DNA, and to cellular proteins to
produce protein adducts [10] that cause the dysfunction
and death of hepatocytes, leading to liver necrosis [8].
Thus, it is plausible to assume that free radicals and
oxidative processes play an important role in
hepatotoxicity.
Previous studies have demonstrated the potential of
MEMM, found to have a high total phenolic content, to exert
antioxidant and anti-inflammatory activities [11]. Higher
total phenolic content has been known to contribute to the
antioxidant activity of extracts [12], while antioxidant
activity has also been linked to the hepatoprotective effect
of some extracts [13]. These findings corroborate with
findings on the ability of MEMM to exert a hepatoprotective
activity. Furthermore, MEMM has also been reported to
contain flavonoid, saponins, and tannins. These compounds
have been reported to exert hepatoprotective activity
[14e16] and thus are suggested to contribute to the
observed hepatoprotection of MEMM.5. Conclusion
The present study demonstrated that the M. malaba-
thricum leaf possesses hepatoprotective activity against
Hepatoprotection from Melastoma malabathricum 55PCM- and CCl4-induced liver toxicity, which requires further
extensive studies.
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